Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen:
Volltext verfügbar? / Dokumentlieferung
doi:10.22028/D291-36654
Titel: | Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study |
VerfasserIn: | Houben-Wilke, Sarah Jörres, Rudolf A. Bals, Robert Franssen, Frits M. E. Gläser, Sven Holle, Rolf Karch, Annika Koch, Armin Magnussen, Helgo Obst, Anne Schulz, Holger Spruit, Martijn A. Wacker, Margarethe E. Welte, Tobias Wouters, Emiel F. M. Vogelmeier, Claus Watz, Henrik |
Sprache: | Englisch |
Titel: | American Journal of Respiratory and Critical Care Medicine |
Bandnummer: | 195 |
Heft: | 2 |
Seiten: | 189-197 |
Verlag/Plattform: | American Thoracic Society |
Erscheinungsjahr: | 2017 |
Freie Schlagwörter: | chronic obstructive pulmonary disease comorbidities peripheral vascular disease health status functional capacity |
DDC-Sachgruppe: | 610 Medizin, Gesundheit |
Dokumenttyp: | Journalartikel / Zeitschriftenartikel |
Abstract: | Rationale: Knowledge about the prevalence of objectively assessed peripheral artery disease (PAD) and its clinical relevance in patients with chronic obstructive pulmonary disease (COPD) is scarce. Objectives: We aimed to: (1) assess the prevalence of PAD in COPD compared with distinct control groups; and (2) study the association between PAD and functional capacity as well as health status. Methods: The ankle–brachial index was used to diagnose PAD (ankle–brachial index ≤ 0.9). The 6-minute-walk distance, health status (St. George’s Respiratory Questionnaire), COPD Assessment Test, and EuroQol-5-Dimensions were assessed in patients enrolled in the German COPD and Systemic Consequences–Comorbidities Network cohort study. Control groups were derived from the Study of Health in Pomerania. Measurements and Main Results: A total of 2,088 patients with COPD (61.1% male; mean [SD] age, 65.3 [8.2] years, GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages I–IV: 9.4, 42.5, 37.5, and 10.5%, respectively) were included, of which 184 patients (8.8%; GOLD stage I–IV: 5.1, 7.4, 11.1, and 9.5%, respectively, vs. 5.9% in patients with GOLD stage 0 in the COPD and Systemic Consequences–Comorbidities Network) had PAD. In the Study of Health in Pomerania, PAD ranged from 1.8 to 4.2%. Patients with COPD with PAD had a significantly shorter 6-minute-walk distance (356 [108] vs. 422 [103] m, P < 0.001) and worse health status (St. George’s Respiratory Questionnaire: 49.7 [20.1] vs. 42.7 [20.0] points, P < 0.001; COPD Assessment Test: 19.6 [7.4] vs. 17.9 [7.4] points, P = 0.004; EuroQol-5-Dimensions visual analog scale: 51.2 [19.0] vs. 57.2 [19.6], P < 0.001). Differences remained significant after correction for several confounders. Conclusions: In a large cohort of patients with COPD, 8.8% were diagnosed with PAD, which is higher than the prevalence in control subjects without COPD. PAD was associated with a clinically relevant reduction in functional capacity and health status. |
DOI der Erstveröffentlichung: | 10.1164/rccm.201602-0354OC |
URL der Erstveröffentlichung: | https://www.atsjournals.org/doi/10.1164/rccm.201602-0354OC |
Link zu diesem Datensatz: | urn:nbn:de:bsz:291--ds-366546 hdl:20.500.11880/33293 http://dx.doi.org/10.22028/D291-36654 |
ISSN: | 1535-4970 1073-449X 1 |
Datum des Eintrags: | 6-Jul-2022 |
Bezeichnung des in Beziehung stehenden Objekts: | Online supplement |
In Beziehung stehendes Objekt: | https://www.atsjournals.org/doi/suppl/10.1164/rccm.201602-0354OC/suppl_file/disclosures.pdf https://www.atsjournals.org/doi/suppl/10.1164/rccm.201602-0354OC/suppl_file/houben-wilke_data_supplement.pdf |
Fakultät: | M - Medizinische Fakultät |
Fachrichtung: | M - Innere Medizin |
Professur: | M - Prof. Dr. Robert Bals |
Sammlung: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Dateien zu diesem Datensatz:
Es gibt keine Dateien zu dieser Ressource.
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt.